Ashwin Kulshrestha

Ashwin Kulshrestha

Auto-generated profile, based on publicly available information

Ashwin Kulshrestha

Icahn School of Medicine at Mount Sinai 1 , New York, New York

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2026 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Closed access
AKAshwin Kulshrestha
Ashwin Kulshrestha
RFRaja M. Flores
Raja M. Flores
SGShubham Gulati
Shubham Gulati
MUMatthew Untalan
Matthew Untalan
TITara Ivic-Pavlicic
Tara Ivic-Pavlicic
BHBrian Housman
Brian Housman
Background: Racial and ethnic disparities in esophageal cancer are well documented, particularly between White and Black patients, but less is known about disparities among other groups or how disparities have evolved. We aimed to characterize longitudinal trends in tumor characteristics, treatment, and survival across racial and ethnic groups. Methods: Using the Surveillance, Epidemiology, and End Results database, we identified 59,573 patients diagnosed with esophageal cancer between 2004 and 2020. Patients were categorized as White, Black, Hispanic, Asian, or Native American. Trends in histology, tumor site, tumor (T) stage, and surgical utilization were analyzed. Multivariable Cox and logistic regression models assessed survival and factors associated with stage at diagnosis. Results: Histologic disparities narrowed, with significant declines in the esophageal squamous cell carcinoma (ESCC):esophageal adenocarcinoma (EAC) ratio among White, Black, and Hispanic patients. ESCC remained predominant among Black and Asian patients. Across most groups, T1 diagnoses decreased whereas T3 increased, making T3 the most common stage by 2020. Surgical utilization declined among White patients and remained lower among Black patients. In adjusted analyses, Black race was associated with worse survival, whereas Asian race was associated with improved survival. Conclusions: Although histologic disparities are narrowing, concerning shifts across groups toward later T-stage diagnosis and declining surgical utilization highlight emerging challenges in early detection and treatment. Impact: These findings update prior characterizations of disparities in esophageal cancer and identify emerging shifts in histology, stage at diagnosis, and treatment utilization, underscoring the need for targeted early detection strategies and structural interventions to reduce inequities in outcomes.

19 June 2026
Verified
Other
Open access
AKAshwin Kulshrestha
Ashwin Kulshrestha
RFRaja M. Flores
Raja M. Flores
SGShubham Gulati
Shubham Gulati
MUMatthew Untalan
Matthew Untalan
TITara Ivic-Pavlicic
Tara Ivic-Pavlicic
BHBrian Housman
Brian Housman
Supplementary Figure S1 shows Kaplan-Meier curves by race and ethnicity.

19 June 2026
Verified
Other
Open access
AKAshwin Kulshrestha
Ashwin Kulshrestha
RFRaja M. Flores
Raja M. Flores
SGShubham Gulati
Shubham Gulati
MUMatthew Untalan
Matthew Untalan
TITara Ivic-Pavlicic
Tara Ivic-Pavlicic
BHBrian Housman
Brian Housman
Supplementary Table S2 shows results from a multivariate comparison of factors associated with T3/T4 stage at diagnosis.

27 October 2026 in Urology
Verified
Journal Article
Closed access
MGMichael Gallagher
Michael Gallagher
JHJonathan Huynh
Jonathan Huynh
DWDaniel Wang
Daniel Wang
AKAshwin Kulshrestha
Ashwin Kulshrestha
JVJuan Sebastian Arroyave Villada
Juan Sebastian Arroyave Villada
MPMichael A. Palese
Michael A. Palese

19 June 2026
Verified
Other
Open access
AKAshwin Kulshrestha
Ashwin Kulshrestha
RFRaja M. Flores
Raja M. Flores
SGShubham Gulati
Shubham Gulati
MUMatthew Untalan
Matthew Untalan
TITara Ivic-Pavlicic
Tara Ivic-Pavlicic
BHBrian Housman
Brian Housman
Supplementary Table S1 lists ICD-O-3 codes and the corresponding histology classification.

19 June 2026
Verified
Other
Open access
AKAshwin Kulshrestha
Ashwin Kulshrestha
RFRaja M. Flores
Raja M. Flores
SGShubham Gulati
Shubham Gulati
MUMatthew Untalan
Matthew Untalan
TITara Ivic-Pavlicic
Tara Ivic-Pavlicic
BHBrian Housman
Brian Housman
Background:Racial and ethnic disparities in esophageal cancer are well documented, particularly between White and Black patients, but less is known about disparities among other groups or how disparities have evolved. We aimed to characterize longitudinal trends in tumor characteristics, treatment, and survival across racial and ethnic groups.Methods:Using the Surveillance, Epidemiology, and End Results database, we identified 59,573 patients diagnosed with esophageal cancer between 2004 and 2020. Patients were categorized as White, Black, Hispanic, Asian, or Native American. Trends in histology, tumor site, tumor (T) stage, and surgical utilization were analyzed. Multivariable Cox and logistic regression models assessed survival and factors associated with stage at diagnosis.Results:Histologic disparities narrowed, with significant declines in the esophageal squamous cell carcinoma (ESCC):esophageal adenocarcinoma (EAC) ratio among White, Black, and Hispanic patients. ESCC remained predominant among Black and Asian patients. Across most groups, T1 diagnoses decreased whereas T3 increased, making T3 the most common stage by 2020. Surgical utilization declined among White patients and remained lower among Black patients. In adjusted analyses, Black race was associated with worse survival, whereas Asian race was associated with improved survival.Conclusions:Although histologic disparities are narrowing, concerning shifts across groups toward later T-stage diagnosis and declining surgical utilization highlight emerging challenges in early detection and treatment.Impact:These findings update prior characterizations of disparities in esophageal cancer and identify emerging shifts in histology, stage at diagnosis, and treatment utilization, underscoring the need for targeted early detection strategies and structural interventions to reduce inequities in outcomes.